PRICE T ROWE ASSOCIATES INC /MD/

Position in NAUT — Nautilus Biotechnology, Inc.

CIK 80255 BALTIMORE, MD

Position in NAUT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$76,221

+$62,378 QoQ

Shares Held

40,760

+153.5% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#49

of 93 holders

Holding Since

Jun 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. NAUT ranks #289 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$76,221	40,760	+153.5%	Shares	Defined	2026-08-14
2025-03-31	$13,843	16,078	0.0%	Shares	Defined	2025-05-14
2024-12-31	$27,011	16,078	0.0%	Shares	Defined	2025-02-14
2024-09-30	$45,822	16,078	0.0%	Shares	Defined	2024-11-14
2024-06-30	$37,622	16,078	0.0%	Shares	Defined	2024-08-14
2024-03-31	$47,269	16,078	+53.9%	Shares	Defined	2024-05-15
2023-09-30	$33,022	10,450	+4.4%	Shares	Defined	2023-11-14
2023-06-30	$38,746	10,012	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.